WoundCentrics Chief Medical Officer has research published in Medical Journal

Press Release:  For Immediate Release – January 2020

WoundCentrics Chief Medical Officer has Research published in Medical Journal

In January, 2020, Marcus Gitterle, MD, Chief Medical Officer of WoundCentrics, LLC of New Braunfels, Texas, saw publication of a case series in the Journal of Biological Regulators and Homeostatic Agents entitled:

"TREATMENT WITH NOVEL HYBENX® ROOT CANAL CLEANSER SUGGESTS BIOFILMS BLOCKED HEALING OF HUMAN WOUNDS: CASE SERIES"

The paper* discusses the use of a new anti-biofilm strategy which has been shown to be universally effective at killing all types of bacteria and fungi with a 10 second, one-shot treatment.

While this treatment methodology has seen extensive use in dentistry, its use in wound care is currently novel. This case series illustrates the applicability of such anti-biofilm strategies to wound care in general, and especially the care of chronic, refractory, non-healing ulcers.

WoundCentrics, LLC encourages its clinicians to engage in clinical research, and to publish in peer-reviewed journals, to help advance the state-of-the-art in wound care.

*TREATMENT WITH NOVEL HYBENX® ROOT CANAL CLEANSER SUGGESTS BIOFILMS BLOCKED HEALING OF HUMAN WOUNDS: CASE SERIES, Gitterle, M, JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS ,   Vol. 34, No. 1 (S1), xx-xx (2020)